FOXO TECHNOLOGIES INC. Notes Payable, Current
FOXO TECHNOLOGIES INC. (FOXO) had Notes Payable, Current of $11.64 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-14
- 2026-06-30: Notes Payable, Current $11.64M.
- 2026-03-31: Notes Payable, Current $3.21M.
- 2025-12-31: Notes Payable, Current $2.15M.
- 2025-09-30: Notes Payable, Current $2.50M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.64M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.21M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.15M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.50M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.37M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $2.59M 10-Q/A · filed 2025-08-19 | $2.95M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $7.28M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $9.56M 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $7.98M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $386.00K 10-Q · filed 2024-06-28 | |
| 2023-12-31 | $4.99M 10-Q · filed 2024-11-19 | $4.20M 10-Q · filed 2024-08-19 |
| 2023-06-30 | $3.86M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.37M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.41M 10-Q · filed 2023-08-10 | |
| 2022-06-30 | $560.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |